The most recent short interest data was recently released for the 04/15/2019 settlement date, and Clovis Oncology Inc (NASDAQ:CLVS) is one of the most shorted stocks of the Russell 3000, based on 7.37 "days to cover" versus the median component at 5.30. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then divided by the average daily volume, to express the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
In the case of Clovis Oncology Inc (NASDAQ:CLVS), the total short interest at the 04/15/2019 settlement date was 9,046,691 shares, which compares to the average daily trading volume of just 1,226,748 shares, for a "days to cover" ratio of 7.37.
When short sellers eventually cover their positions, by definition there must be buying activity because a share that is currently sold short must be purchased to be covered. At the present levels of short interest, if from this point forward every single CLVS share traded represented a short position being closed, then at the average daily volume of 1,226,748 shares it would only be during the 8th trading day that every short position would be closed.
So it would stand to reason that should some unexpectedly good news come out, and short sellers did not have 8 days of patience but instead wanted to cover their short positions very suddenly, that situation could result in sending the stock higher until the higher price produces enough sellers to generate the necessary volume to close out those positions quickly.
Clovis Oncology Inc (NASDAQ:CLVS) has something relatively rare for a stock with this much short interest, that being insiders taking the other side of the trade. Looking back over the trailing six month period, CLVS has seen 2 different instances of insider buying, as summarized by the table below:
Patrick J. Mahaffy
President and CEO
James C. Blair
Below is a chart showing the "days to cover" for CLVS over time:
And looking at the chart below, CLVS's low point in its 52 week range is $2.93 per share, with $32.05 as the 52 week high point — that compares with a last trade of $7.46.
In recent trading, shares of Clovis Oncology Inc (NASDAQ:CLVS) were changing hands at $7.46/share.
This Article's Word Cloud:ArialCLVSClovisOncologyaveragebecausebeingbelowbuyingchartcloseclosedcomparescoverdailydatadatedayseveryfillColorhigherinterestmostmustnumberoverperiodpointpositionpositionsrecentrepresentedsellerssettlementsharesharesshortstockthattheirthenthistotaltradetradedtradingvolumeweekwithwould
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.